Страна: Ирландия
Язык: английский
Источник: HPRA (Health Products Regulatory Authority)
OMEGA-3-ACID ETHYL ESTERS 90
Teva Pharma B.V.
OMEGA-3-ACID ETHYL ESTERS 90
1000 Milligram
Capsules, Soft
Product subject to prescription which may be renewed (B)
Withdrawn
2014-04-24
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Omega-3-acid-ethyl esters 1000 mg Soft Capsules 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each soft capsule contains 1,000 mg of omega-3-acid ethyl esters 90 comprising principally 840 mg eicosapentaenoic acid (EPA) ethyl ester (460 mg) and docosahexaenoic acid (DHA) ethyl ester (380 mg). For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Capsule, soft. Oblong, transparent, elastic soft gelatin capsule containing clear, light-yellow oil. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Hypertriglyceridaemia Endogenous hypertriglyceridaemia as a supplement to diet when dietary measures alone are insufficient to produce an adequate response: - type IV in monotherapy, - type IIb/III in combination with statins, when control of triglycerides is insufficient. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Hypertriglyceridaemia Initial treatment two capsules daily. If adequate response is not obtained, the dose may be increased to four capsules daily. The capsules may be taken with food to avoid gastrointestinal disturbances. There is no information regarding the use of omega-3-acid ethyl esters 90 in children and adolescents, in elderly patients over 70 years of age, or in patients with hepatic impairment (see section 4.4), and only limited information regarding the use in patients with renal impairment. 4.3 CONTRAINDICATIONS Hypersensitivity to the active substance or to any of the excipients. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE Warnings Because of the moderate increase in bleeding time (with the high dosage, _i.e. _4 capsules), patients receiving anticoagulant therapy must be monitored and the dosage of anticoagulant adjusted if necessary (see section 4.5). Use of this medicinal product does not elim Прочитать полный документ